FDA Inspection 1242050 — Kyriako Martakis
The FDA completed an inspection of Kyriako Martakis on May 31, 2024 in Giesen. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 31, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Giesen (Germany)
Additional Details
Clinical Investigator (CI)